Shilpa Medicare: TDS Communication for Final Dividend on 17 Aug 2026
Shilpa Medicare announced TDS procedures for its Re. 0.60 per share final dividend, recommended on May 22, 2026. Record date is September 4, 2026, and AGM is September 11, 2026. Shareholders must submit updated details and required tax documents by September 2, 2026, to ensure correct TDS application for resident and non-resident shareholders.
This is a standard communication regarding tax compliance for dividend distribution and is unlikely to have a significant impact on the company's stock price or business operations.
The announcement is a procedural update regarding tax deduction on dividend payments and does not contain financial results or business performance indicators that would significantly alter the company's valuation or outlook.
Shilpa Medicare Limited has issued a communication to its shareholders regarding the deduction of Tax at Source (TDS) on the final dividend. The Board of Directors, in their meeting on May 22, 2026, recommended a dividend of Re. 0.60 per equity share for the financial year ended March 31, 2026. The record date for this dividend is set for September 4, 2026, and the dividend, if approved by shareholders, will be paid within 30 days of the Annual General Meeting (AGM) scheduled for September 11, 2026.
The company has outlined the TDS procedures for both resident and non-resident shareholders as per the Indian Income Tax Act, 2025. For resident shareholders, TDS will be at 10% unless exempt, with mandatory PAN submission. Specific rules apply to resident individuals, including a threshold of ₹10,000 for aggregate dividend payments and the option to submit Form 121. For non-resident shareholders, the TDS rate is 20% (plus surcharge and cess) or the applicable tax treaty rate, whichever is lower, requiring documents like PAN, Tax Residency Certificate (TRC), and Form 41.
Shareholders are urged to update their details such as PAN, residential status, and bank mandates in their demat accounts. The company will rely on these details as available on the record date for TDS compliance. Shareholders are requested to submit necessary documents by September 2, 2026, to ensure correct TDS application. No further communication regarding tax determination will be entertained after this date. The company will issue TDS certificates post-payment of the interim dividend. Queries can be directed to KFin Technologies Limited.
What to do with a filing like this
Shilpa Medicare Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shilpa Medicare Limited. Read the original for the full detail.